Shafique Virani - Feb 4, 2022 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role: Chief Corp. Dev. Officer
Signature: /s/ Nathan Hatfield, attorney-in-fact
Stock symbol: RXRX
Transactions as of: Feb 4, 2022
Transactions value $: -$12,700
Form type: 4
Date filed: 2/8/2022, 08:11 PM
Previous filing: Jun 4, 2021
Next filing: May 18, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RXRX	Class A Common Stock	Award	$0	+40.2K	+63.42%	$0.00	104K	Feb 4, 2022	Direct	F1, F2
transaction	RXRX	Class A Common Stock	Award	$0	+2.72K	+2.62%	$0.00	106K	Feb 4, 2022	Direct	F3
transaction	RXRX	Class A Common Stock	Tax liability	-$12.7K	-1.11K	-1.05%	$11.40	105K	Feb 4, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RXRX	Stock Option (Right to Buy)	Award	$0	+80.5K		$0.00	80.5K	Feb 4, 2022	Class A Common Stock	80.5K	$11.40	Direct	F4
transaction	RXRX	Stock Option (Right to Buy)	Award	$0	+5.44K		$0.00	5.44K	Feb 4, 2022	Class A Common Stock	5.44K	$11.40	Direct
holding	RXRX	Stock Option (Right to Buy)						687K	Feb 4, 2022	Class A Common Stock	687K	$2.22	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2022 and every three months thereafter.
F2	Includes 382 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on November 22, 2021.
F3	This RSU vested immediately upon the grant date.
F4	The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F5	One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.